Cochlear Limited (Cochlear) announced the appointment of Michael del Prado to the Cochlear Board. Mr. del Prado's appointment will become effective on 1 January 2022. Mr. del Prado has had a distinguished executive career of more than 30 years in the medical device and pharmaceutical industries with senior leadership roles in Johnson and Johnson medical device businesses across the globe, including the United States, Europe, the Middle East & Africa, and Asia-Pacific. Mr. del Prado is currently a Non-Executive Director of Ambu A/S, a medical device company listed on the NASDAQ OMX Copenhagen. He is a graduate of BS Industrial Engineering and also completed MBA and MA degrees. Mr. del Prado will be a Non-Executive Director and is considered by the Board to be independent.